Please assess the completion status of the following clinical trial:

Trial Title: Decrease Emergence Agitation and Provide Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ages 2-10 ASA rating of I-III undergoing general anesthesia tonsillectomy with and without adenoidectomy~Exclusion Criteria:~* diagnosis of anxiety disorder or chronic pain syndrome chronic disabilities or developmental delays are currently on psychotherapeutic or sedating medication are on chronic pain medication or opiate any known adverse effect to the study drug any known cardiac abnormalities

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- fentanyl (Type: ACTIVE_COMPARATOR): fentanyl bolus 1ug.kg-1
- dexmedetomidine (Type: EXPERIMENTAL): dexmedetomidine 2ug.kg-1 over 10 min followed by 0.7ug.kg-1.h-1

Based on this trial design, predict the completion outcome and termination type (if applicable).